Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis.
Palmerini E, Sanfilippo R, Grignani G, Buonadonna A, Romanini A, Badalamenti G, Ferraresi V, Vincenzi B, Comandone A, Pizzolorusso A, Brunello A, Gelsomino F, De Pas T, Ibrahim T, Gurrieri L, Grosso F, Zanelli F, Pantaleo MA, Milesi L, Ciuffreda L, Ferrari V, Marchesi E, Quattrini I, Righi A, Setola E, Carretta E, Casali PG, Picci P, Ferrari S. Palmerini E, et al. Among authors: pizzolorusso a. Front Oncol. 2022 Dec 8;12:1042479. doi: 10.3389/fonc.2022.1042479. eCollection 2022. Front Oncol. 2022. PMID: 36568164 Free PMC article.
Current status of targeted therapies in advanced gastric cancer.
De Vita F, Giuliani F, Silvestris N, Rossetti S, Pizzolorusso A, Santabarbara G, Galizia G, Colucci G, Ciardiello F, Orditura M. De Vita F, et al. Among authors: pizzolorusso a. Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S29-34. doi: 10.1517/14728222.2011.652616. Epub 2012 Mar 23. Expert Opin Ther Targets. 2012. PMID: 22443228 Review.
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group.
Palmerini E, Sanfilippo R, Grignani G, Buonadonna A, Romanini A, Badalamenti G, Ferraresi V, Vincenzi B, Comandone A, Pizzolorusso A, Brunello A, Gelsomino F, Pas T, Ibrahim T, Grosso F, Zanelli F, Pantaleo MA, Milesi L, Ciuffreda L, Ferrari V, Marchesi E, Quattrini I, Righi A, Setola E, Carretta E, Picci P, Ferrari S. Palmerini E, et al. Among authors: pizzolorusso a. Cancers (Basel). 2021 Mar 2;13(5):1053. doi: 10.3390/cancers13051053. Cancers (Basel). 2021. PMID: 33801399 Free PMC article.
Is immunotherapy in the future of therapeutic management of sarcomas?
Clemente O, Ottaiano A, Di Lorenzo G, Bracigliano A, Lamia S, Cannella L, Pizzolorusso A, Di Marzo M, Santorsola M, De Chiara A, Fazioli F, Tafuto S. Clemente O, et al. Among authors: pizzolorusso a. J Transl Med. 2021 Apr 26;19(1):173. doi: 10.1186/s12967-021-02829-y. J Transl Med. 2021. PMID: 33902630 Free PMC article. Review.
Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma.
Botti G, Scognamiglio G, Marra L, Pizzolorusso A, Di Bonito M, De Cecio R, Cantile M, De Chiara A. Botti G, et al. Among authors: pizzolorusso a. J Cancer. 2017 Sep 15;8(16):3166-3172. doi: 10.7150/jca.19060. eCollection 2017. J Cancer. 2017. PMID: 29158788 Free PMC article.
The Complex Management of the Breast Angiosarcoma: A Retrospective Study.
Cannella L, Perri F, Clemente O, von Arx C, Pizzolorusso A, Di Bonito M, Bracigliano A, Di Marzo M, Della Vittoria Scarpati G, De Chiara A, Tafuto S. Cannella L, et al. Among authors: pizzolorusso a. Oncology. 2023;101(4):234-239. doi: 10.1159/000525146. Epub 2022 Dec 20. Oncology. 2023. PMID: 36538913
19 results